Literature DB >> 18259034

Activation of local chorionic villi angiotensin II levels but not angiotensin (1-7) in preeclampsia.

Lauren Anton1, David C Merrill, Liomar A A Neves, Kathryn Stovall, Patricia E Gallagher, Debra I Diz, Cheryl Moorefield, Courtney Gruver, Carlos M Ferrario, K Bridget Brosnihan.   

Abstract

The chorionic villi in the placenta are responsible for the regulation of fetal oxygen and nutrient transport. Although the peripheral renin-angiotensin system is activated during normal pregnancy, the regulation of the local chorionic villi renin-angiotensin system remains unknown. Therefore, placental chorionic villous tissue was collected from nulliparous third-trimester normotensive or preeclamptic subjects and was analyzed for angiotensin peptide content, angiotensinogen, renin, angiotensin-converting enzyme (ACE), ACE2, neprilysin, angiotensin II type 1 (AT(1)), angiotensin II type 2, Mas receptor mRNAs, and angiotensin receptor density and subtype. Angiotensin II in chorionic villi was significantly higher in preeclamptic subjects, whereas angiotensin (1-7) was not different. Angiotensinogen and AT(1) receptor gene expression was significantly higher in preeclamptic subjects. No differences were observed in renin, ACE, ACE2, or neprilysin gene expression. Mas receptor mRNA in preeclamptic subjects was decreased. The AT(1) receptor was the predominant receptor subtype in normal and preeclamptic chorionic villi. There was no difference in the density of the AT(1,) angiotensin II type 2, and angiotensin (1-7) receptors. These results indicate that enhanced chorionic villous expression of angiotensin II may result from increased angiotensinogen. Elevated angiotensin II, acting through the AT(1) receptor, may favor vasoconstriction in placental chorionic villi and contribute to impaired fetal blood flow and decreased fetal nutrition observed during preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18259034      PMCID: PMC2705753          DOI: 10.1161/HYPERTENSIONAHA.107.103861

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  40 in total

1.  VASCULAR REACTIVITY TO ANGIOTENSIN II AND NOREPINEPHRINE IN PREGNANT WOMEN.

Authors:  L C CHESLEY; E TALLEDO; C S BOHLER; F P ZUSPAN
Journal:  Am J Obstet Gynecol       Date:  1965-03-15       Impact factor: 8.661

2.  Soluble endoglin contributes to the pathogenesis of preeclampsia.

Authors:  Shivalingappa Venkatesha; Mourad Toporsian; Chun Lam; Jun-ichi Hanai; Tadanori Mammoto; Yeon M Kim; Yuval Bdolah; Kee-Hak Lim; Hai-Tao Yuan; Towia A Libermann; Isaac E Stillman; Drucilla Roberts; Patricia A D'Amore; Franklin H Epstein; Frank W Sellke; Roberto Romero; Vikas P Sukhatme; Michelle Letarte; S Ananth Karumanchi
Journal:  Nat Med       Date:  2006-06-04       Impact factor: 53.440

3.  Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies.

Authors:  G Valdés; L A A Neves; L Anton; J Corthorn; C Chacón; A M Germain; D C Merrill; C M Ferrario; R Sarao; J Penninger; K B Brosnihan
Journal:  Placenta       Date:  2005-04-25       Impact factor: 3.481

4.  Angiotensinogen T235 expression is elevated in decidual spiral arteries.

Authors:  T Morgan; C Craven; L Nelson; J M Lalouel; K Ward
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

5.  Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor.

Authors:  G Wallukat; V Homuth; T Fischer; C Lindschau; B Horstkamp; A Jüpner; E Baur; E Nissen; K Vetter; D Neichel; J W Dudenhausen; H Haller; F C Luft
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

6.  The physiological response of the vessels of the placental bed to normal pregnancy.

Authors:  I Brosens; W B Robertson; H G Dixon
Journal:  J Pathol Bacteriol       Date:  1967-04

7.  Reproductive tissue renin gene expression in preeclampsia.

Authors:  D M Shah; J M Banu; J M Chirgwin; R R Tekmal
Journal:  Hypertens Pregnancy       Date:  2000       Impact factor: 2.108

Review 8.  The renin-angiotensin-aldosterone system in pre-eclampsia.

Authors:  M A Brown; J Wang; J A Whitworth
Journal:  Clin Exp Hypertens       Date:  1997 Jul-Aug       Impact factor: 1.749

9.  Determination of renin, angiotensin converting enzyme and angiotensin II levels in human placenta, chorion and amnion from women with pregnancy induced hypertension.

Authors:  M K Kalenga; K Thomas; M de Gasparo; R De Hertogh
Journal:  Clin Endocrinol (Oxf)       Date:  1996-04       Impact factor: 3.478

10.  Adrenal, kidney, and heart angiotensins in female murine Ren-2 transfected hypertensive rats.

Authors:  P S Senanayake; R R Smeby; A S Martins; A Moriguchi; H Kumagai; D Ganten; K B Brosnihan
Journal:  Peptides       Date:  1998       Impact factor: 3.750

View more
  36 in total

Review 1.  Molecular Mechanisms of Preeclampsia.

Authors:  Tammy Hod; Ana Sofia Cerdeira; S Ananth Karumanchi
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-20       Impact factor: 6.915

2.  Maternal protein restriction reduces expression of angiotensin I-converting enzyme 2 in rat placental labyrinth zone in late pregnancy.

Authors:  Haijun Gao; Uma Yallampalli; Chandra Yallampalli
Journal:  Biol Reprod       Date:  2012-02-09       Impact factor: 4.285

Review 3.  AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia.

Authors:  Florian Herse; Anne Cathrine Staff; Lydia Hering; Dominik N Müller; Friedrich C Luft; Ralf Dechend
Journal:  J Mol Med (Berl)       Date:  2008-04-09       Impact factor: 4.599

Review 4.  Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.

Authors:  Juanjuan Chen; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-22       Impact factor: 3.622

5.  A novel rodent model of pregnancy complications associated with genetically determined angiotensin-converting enzyme (ACE) activity.

Authors:  Eugenia Mata-Greenwood; Arlin B Blood; LeeAnna D Sands; Shannon L Bragg; Daliao Xiao; Lubo Zhang
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-01-23       Impact factor: 4.310

6.  Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: an in vitro study.

Authors:  Lauren Anton; David C Merrill; Liomar A A Neves; Courtney Gruver; Cheryl Moorefield; K Bridget Brosnihan
Journal:  Reprod Biol Endocrinol       Date:  2010-11-04       Impact factor: 5.211

7.  Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia.

Authors:  J S Possomato-Vieira; R A Khalil
Journal:  Adv Pharmacol       Date:  2016-06-14

8.  AT1, AT2, and AT(1-7) receptor expression in the uteroplacental unit of normotensive and hypertensive rats during early and late pregnancy.

Authors:  L M Yamaleyeva; L A A Neves; K Coveleskie; D I Diz; P E Gallagher; K B Brosnihan
Journal:  Placenta       Date:  2013-04-17       Impact factor: 3.481

Review 9.  Vasodilator factors in the systemic and local adaptations to pregnancy.

Authors:  Gloria Valdes; Peter Kaufmann; Jenny Corthorn; Rafaela Erices; K Bridget Brosnihan; Janae Joyner-Grantham
Journal:  Reprod Biol Endocrinol       Date:  2009-07-31       Impact factor: 5.211

Review 10.  Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy.

Authors:  K G Pringle; K L Kind; A N Sferruzzi-Perri; J G Thompson; C T Roberts
Journal:  Hum Reprod Update       Date:  2009-11-19       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.